Bayforest Capital LTD Ultragenyx Pharmaceutical Inc. Transaction History
Bayforest Capital LTD
- $121 Billion
- Q1 2025
A detailed history of Bayforest Capital LTD transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Bayforest Capital LTD holds 9,190 shares of RARE stock, worth $334,516. This represents 0.15% of its overall portfolio holdings.
Number of Shares
9,190
Previous 3,144
192.3%
Holding current value
$334,516
Previous $132 Million
38.72%
% of portfolio
0.15%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding RARE
# of Institutions
336Shares Held
88.9MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$364 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$204 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$152 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$117 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$95.3 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.55B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...